AI Article Synopsis
- Treatment of large thrombi, particularly in the vascular system, poses significant challenges.
- A case study describes a 51-year-old man with a large thrombus in his inferior vena cava that reached the heart, where high surgical risks prompted the use of the AngioVac system for percutaneous embolectomy.
- The report also includes a review of existing literature on this innovative technique for thrombus removal.
Article Abstract
Treatment of large, fresh thrombi in the vascular system can be challenging. AngioVac, a cardiopulmonary pump system, has been used to remove large thrombi and even some tumors by a percutaneous route. We report here a case of a 51-year-old man who presented with a large thrombus (7.5 × 1.5 cm) in his inferior vena cava, extending into his right atrium and right ventricle. Because the surgical risk was high, we attempted percutaneous embolectomy via the AngioVac aspiration system. We also review the literature concerning this emerging technique.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179160 | PMC |
| http://dx.doi.org/10.14503/THIJ-15-5502 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Catheter-Directed Aspiration for Right Atrial and Right Ventricular Masses: Trends in Use Over the Years and Comparison Between Percutaneous and Surgical Thrombectomy for Clot in Transit.
Catheter Cardiovasc Interv
January 2025
John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois, USA.
Background: Percutaneous mechanical aspiration thrombectomy is increasingly being employed as a less invasive alternative for managing right heart masses, including clot in transit.
Aims: We aimed to analyze trends in the use of catheter-directed aspiration (CDA) for right heart masses. Additionally, we analyzed in-hospital outcomes of percutaneous versus surgical approaches for patients with CIT and PE.
Concurrent acute myocardial infarction and acute ischemic stroke in a diabetic patient undergoing chemotherapy for non-Hodgkin lymphoma: Should I administer thrombolytic therapy? A case report.
Egypt Heart J
December 2024
Jakaya Kikwete Cardiac Institute, P.O. Box 65141, Dar es Salaam, Tanzania.
Background: Concurrent ST-elevation myocardial infarction (STEMI) and acute ischemic stroke (AIS) are extremely rare, and their management remains perplexing due to the absence of high-quality evidence and limited resources. For the first time, we report a rare, preventable, and suboptimally managed case of concurrent AIS and STEMI in a patient with non-Hodgkin lymphoma (NHL) who received cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) chemotherapy.
Case Presentation: A 59-year-old postmenopausal woman of African origin with a background history of type 2 diabetes mellitus presented to the Jakaya Kikwete Cardiac Institute with sudden onset of left-sided weakness and typical ischemic chest pain for 3 days.
Efficacy and Safety of Systemic Thrombolysis and Catheter-Directed Therapy in Pulmonary Embolism: A Narrative Review.
Cureus
November 2024
Interventional Radiology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, GBR.
Pulmonary embolism (PE) is the third most frequent cause of acute cardiovascular presentation after myocardial infarction and stroke. The treatment approach for PE consists of hemodynamic and respiratory support, anticoagulation, reperfusion treatment, and vena cava filters. Reperfusion treatment consists of systemic thrombolysis (recombinant tissue-type plasminogen activator, streptokinase, and urokinase); percutaneous catheter-directed therapy (CDT); and surgical embolectomy.
View Article and Find Full Text PDFEffective Management of Acute Pulmonary Embolism and Deep Vein Thrombosis: Insights From a Case Series on Procedure Benefits.
Cureus
October 2024
Heart, Vascular, and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Pulmonary thromboembolectomy is an essential intervention for managing acute pulmonary embolism (PE), with various treatment approaches including systemic thrombolysis, open surgical embolectomy, and percutaneous mechanical thrombectomy. Multimodal approaches are crucial for improving outcomes in massive and submassive PE cases, with integration across disciplines such as vascular surgery and interventional radiology enhancing comprehensive care. This manuscript will discuss a case series featuring two patients diagnosed with acute PE.
View Article and Find Full Text PDFCase report of simultaneous phlegmasia cerulea dolens and acute limb ischemia.
Int J Surg Case Rep
December 2024
Department of Vascular surgery, University hospital of Bratislava, Faculty of Medicine - Comenius University, Slovak Republic.
Article Synopsis
- Phlegmasia cerulea dolens (PCD) is a serious condition caused by massive deep vein thrombosis that can threaten both life and limbs, often requiring urgent treatment options such as endovascular therapy or surgical embolectomy in specific cases.
- A patient case illustrated simultaneous PCD with acute limb ischemia, showing symptoms like abdominal pain, cyanosis, and motor deficits, leading to a successful combined surgical embolectomy to resolve the issues.
- This report emphasizes that there are no formal guidelines for treating PCD and stresses the necessity for personalized treatment strategies and comprehensive care access.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!